뒤로
Ascentage Pharma Group International(06855.HK) 가격
06855.HK 주가 차트
ASCENTAGE-B (06855.HK)
Ascentage Pharma Group International
HK$52.15
-2.79%
$-1.5
장 종료: Jan 16, 16:00:00 HKT
주요 통계
이전 종가
$53.4
시가
$53.65
일일 범위
$51.85 - $54.1
52주 범위
$31.35 - $95.35
거래량
1.9M
평균 거래량
1.9M
EPS(TTM)
-4.04
배당수익률
--
시가총액
$19.3B
ASCENTAGE-B란 무엇인가요?
Ascentage Pharma Group International Co., Ltd. is a clinical-stage biotechnology company. The company is headquartered in Suzhou, Jiangsu and currently employs 605 full-time employees. The company went IPO on 2019-10-28. The firm's main products include Olverembatinib (HQP1351), Lisaftoclax (APG-2575), Alrizomadlin (APG-115), Pelcitoclax (APG-1252), APG-5918, and APG-2449. The firm's products are primarily used to treat chronic myeloid leukemia (CML), acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL), acute lymphoblastic leukemia (ALL), myelodysplastic syndrome (MDS) and multiple myeloma (MM). The firm primarily conducts its businesses in domestic market.
